MEDONCARE
LIVE

Serial Number

79236112

Owner

Medoncare Pharmaceutical Co.,Ltd.

Filing Date

Dec 11, 2017

Add to watchlist:

No watchlists yet
View on USPTO

MEDONCARE Trademark

Serial Number: 79236112 • Registration: 5859327

MEDONCARE is a trademark filed by Medoncare Pharmaceutical Co.,Ltd. on December 11, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 30 (Staple Foods), Class 32 (Light Beverages). The application is currently registered and active.

Owner Contact Info

Medoncare Pharmaceutical Co.,Ltd.

Room 301, Building B1,

Entity Type: 03

Trademark Details

Filing Date

December 11, 2017

Registration Date

September 17, 2019

Published for Opposition

July 2, 2019

Cancellation Date

April 3, 2026

Goods & Services

Medicinal tonics for the treatment of cancer, prostatitis, benign prostatic hyperplasia, Alzheimer's disease, rheumatoid arthritis, bone injury diseases, thyroid nodules, diabetes, HBV, HIV, fatty liver disease, and alcoholic liver disease; medicines for human purposes for the treatment of cancer, prostatitis, benign prostatic hyperplasia, Alzheimer's disease, rheumatoid arthritis, bone injury diseases, thyroid nodules, diabetes, HBV, HIV, fatty liver disease, and alcoholic liver disease; medicinal drinks; capsules for medicines sold empty; pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; chemical-pharmaceutical preparations for the treatment of cancer, prostatitis, benign prostatic hyperplasia, Alzheimer's disease, rheumatoid arthritis, bone injury diseases, thyroid nodules, diabetes, HBV, HIV, fatty liver disease, and alcoholic liver disease; pre-filled syringes for medical purposes for the treatment of cancer, asthma, and insomnia; medicated lozenges for pharmaceutical purposes; traditional Chinese medicines in the nature of medicinal herbs

Urological surgical apparatus and instruments; medical sprayers for cleaning gums and teeth used in dentists' offices during dental procedures; aerosol masks for medical purposes; apparatus for use in medical analysis, namely, stethoscopes and X-ray CT scanners; testing apparatus for medical purposes, namely, surgical microscopes and X-ray CT scanners; massage apparatus; medical apparatus and instruments, namely, stethoscopes and X-ray CT scanners; receptacles for applying medicines, namely, insulin injectors sold empty and implantable subcutaneous drug delivery devices sold empty; vibromassage apparatus; fumigation apparatus for medical purposes

Non-alcoholic beverages, namely, fruit drinks, soda pop, and drinking water; isotonic beverages; vegetable beverages

Pastries; condiments, namely, chutney, minced garlic, and prepared horseradish; béchamel sauce; food leavening agents; food flavorings being non-essential oils; vanilla flavorings for food or beverages; vegetal preparations for use as coffee substitutes; tea; tea-based beverages; natural sweeteners

Filing History

CANCELLED SECTION 71
Apr 3, 2026 C71T
CHANGE OF NAME/ADDRESS REC'D FROM IB
Nov 7, 2020 ADCH
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 31, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 13, 2020 FICS
FINAL DISPOSITION PROCESSED
Jan 13, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 17, 2019 FICR
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Oct 7, 2019 CORN
REGISTERED-PRINCIPAL REGISTER
Sep 17, 2019 R.PR
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 5, 2019 CRCV
NEW REPRESENTATIVE AT IB RECEIVED
Jul 4, 2019 NREP
PUBLISHED FOR OPPOSITION
Jul 2, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Jun 28, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 12, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 12, 2019 OP2R
NOTICE OF PUBLICATION
Jun 12, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 24, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 23, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 23, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 23, 2019 ERFR
FINAL REFUSAL MAILED
Feb 14, 2019 CNFR
FINAL REFUSAL WRITTEN
Feb 13, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 7, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 7, 2019 CRFA
ASSIGNED TO LIE
Feb 1, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 28, 2019 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Dec 7, 2018 NREP
REFUSAL PROCESSED BY IB
Aug 18, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 2, 2018 RFCS
REFUSAL PROCESSED BY MPU
Aug 2, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 18, 2018 RFCR
NON-FINAL ACTION WRITTEN
Jul 17, 2018 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 17, 2018 MAFR
ASSIGNED TO EXAMINER
Jul 13, 2018 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 13, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 12, 2018 REPR